Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Document Type
Type of study
Language
Year range
1.
Am J Transplant ; 21(4): 1629-1632, 2021 04.
Article in English | MEDLINE | ID: covidwho-852163

ABSTRACT

To date, little is known about the duration and effectiveness of immunity as well as possible adverse late effects after an infection with SARS-CoV-2. Thus it is unclear, when and if liver transplantation can be safely offered to patients who suffered from COVID-19. Here, we report on a successful liver transplantation shortly after convalescence from COVID-19 with subsequent partial seroreversion as well as recurrence and prolonged shedding of viral RNA.


Subject(s)
Antibodies, Viral/blood , COVID-19/complications , End Stage Liver Disease/surgery , Liver Transplantation , Virus Shedding , COVID-19/pathology , Humans , Male , Middle Aged , RNA, Viral/genetics , SARS-CoV-2 , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL
...